NEW YORK (GenomeWeb News) — Agilent Technologies and Gene Logic intend to improve tools and techniques for systems-based biopharmaceutical research, including clinical profiling and pathway mapping, the companies said today.
Under the collaboration, Agilent will provide microarray workflow products, including its GeneSpring bioinformatics platform, while Gene Logic will contribute its biorepository and other databases, the companies said.
The companies said the relationship will also tap their “channels into academic and commercial life science sectors.”
The companies said they are also exploring integrating data from microarray platforms into breast cancer research by conducting array-based comparative genomic hybridization, microRNA, gene-expression methods, and SNP-genotyping studies on tissues from Gene Logic’s tissue repository.
The companies said early results from the studies show a “good correlation” between aCGH and gene expression data, “which could be useful in developing a therapy.”
Gene Logic also said it has become an Agilent Certified Microarray Service Provider. This required proficiency analyzing Agilent’s 60-mer oligo microarrays using Agilent's 2100 Bioanalyzer.